6. Areas for Future Consideration
The Thyroid Cancer QPI Development Group were not able to identify sufficient evidence, or determine appropriate measurability specifications, to address all areas felt to be of key importance in the treatment of thyroid cancer and therefore in improving the quality of care for patients affected by this type of cancer.
The following area for future consideration has been raised across the lifetime of the Thyroid Cancer QPI Development Group:
- Molecular Testing in Medullary Thyroid Cancer
There is a problem
Thanks for your feedback